Market cap
$0 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -195.56 | -961.54 | -431.01 | -4.74 | -16.80 |
| Net Profit | -163.96 | -921.64 | -312.06 | 1.25 | -5.13 |
| EPS | 51.56 | -577.27 | -311.29 | 24.36 | 14.32 |
| Book Value | -- | -- | -92.30 | 35.46 | -9.70 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-24 | Dec-23 |
| EBIT-Margin
| -- | -- | -55,762.22 | -- | -- |
| Net Margin
| -- | 1,425.61 | -44,447.78 | -- | -- |
| Return on equity
| -178.62 | -139.84 | -- | -81.98 | -302.78 |
| Return on Capital
| -98.83 | -89.38 | -- | -34.25 | -124.82 |
| Return on Assets
| -48.48 | -48.73 | -96.67 | -18.20 | -57.68 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.18 | 4.96 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
-34.25
|
-124.82
|
-137.41
|
-114.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
-81.98
|
-302.78
|
-151.11
|
-121.39
|
|
Peer Median
|
-40.29
|
--
|
--
|
--
|
--
|
ROA
-96.67
Lower than Peers by 65.84
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-96.67
|
-18.20
|
-57.68
|
-69.55
|
-72.08
|
|
Peer Median
|
-30.84
|
--
|
--
|
--
|
--
|
EBIT Margin
-55,762.22
Lower than Peers by 55,680.01
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-55,762.22
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-82.21
|
--
|
--
|
--
|
--
|
Net Margin
-44,447.78
Lower than Peers by 44,357.90
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-44,447.78
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-89.88
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.44
Lower than Peers by 0.44
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-0.44
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
-431.01
Lower than Peers by 430.06
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-431.01
|
92.30
|
50.05
|
47.72
|
-138.92
|
|
Peer Median
|
-0.95
|
--
|
--
|
--
|
--
|
Net Profit Growth
-312.06
Lower than Peers by 304.88
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-312.06
|
72.96
|
48.25
|
42.03
|
-123.37
|
|
Peer Median
|
-7.19
|
--
|
--
|
--
|
--
|
EPS Growth
-311.29
Lower than Peers by 325.72
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-311.29
|
0.99
|
0.93
|
-1,719.01
|
-0.48
|
|
Peer Median
|
14.43
|
--
|
--
|
--
|
--
|
Book Value Growth
-274.56
Lower than Peers by 264.10
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-274.56
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.46
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
0.18
|
4.96
|
0.23
|
0.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-1.09
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-1.09
|
0.12
|
0.20
|
0.07
|
0.02
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.33
Lower than Peers by 5.48
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
0.33
|
0.45
|
1.35
|
3.00
|
4.77
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
0.33
Lower than Peers by 5.36
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
0.33
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.69
|
--
|
--
|
--
|
--
|
Interest Coverage
-88.14
Lower than Peers by 86.05
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
-88.14
|
-6.63
|
-404.82
|
-764.57
|
-679.90
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
6,447.78
Higher than Peers by 6,428.80
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
6,447.78
|
--
|
--
|
--
|
--
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
Asset Turnover
0.00
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
5,844.00
|
2,356.31
|
162.14
|
389.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
-0.02
|
0.00
|
0.00
|
-0.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.61
Lower than Peers by 4.74
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
0.61
|
0.01
|
0.00
|
0.00
|
0.10
|
|
Peer Median
|
5.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.01
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
0.01
|
-0.09
|
-0.62
|
0.10
|
0.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
0
Lower than Peers by 147
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Windtree Therapeutics (WINT)
|
0
|
--
|
--
|
--
|
--
|
|
Peer Median
|
147
|
--
|
--
|
--
|
--
|